Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.

<< Back to News

7/8/25 Diltiazem

July 8, 2025

Pfizer is discontinuing all add-vantage products in 2025. 
 
Today we replaced the Diltiazem 100 mg add-vantage with a 125 mg / 125 mL robot-prepared infusion.  These will have a 60-day room temperature BUD and will be stored in the current Pyxis locations.
Changes have been made in Cerner today to select the 125 mL infusion for all new orders.
 
Thank you,

 

Donna Huggins, RPh.
Manager - Pharmacy Sterile Products
Huntsville Hospital
Office - 256-265-6293
Cell - 662-871-2513
donna.huggins@hhsys.org






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.